Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Exploring Atlassian Stock's Decline – What Investors Should Know

Atlassian stock is trading -38.09% below its average target price of $249.51 after dropping -1.2% during today's morning session. Analysts are giving the Large-Cap Software company an average rating of buy and target prices ranging from $175.0 to $480.0 per share.

The stock has an average amount of shares sold short at 3.5%, and a short ratio of 2.5. The company's insiders own 0.45% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 94.2% of Atlassian's shares being owned by this investor type.

Institutions Invested in Atlassian

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 10% 17,430,078 $2,692,291,720
2025-06-30 Blackrock Inc. 6% 10,746,433 $1,659,919,857
2025-06-30 BAILLIE GIFFORD & CO 5% 8,527,513 $1,317,180,143
2025-06-30 JPMORGAN CHASE & CO 2% 3,913,714 $604,521,666
2025-06-30 Artisan Partners Limited Partnership 2% 3,878,133 $599,025,739
2025-06-30 State Street Corporation 2% 3,794,981 $586,181,882
2025-06-30 Capital International Investors 2% 3,632,514 $561,086,838
2025-06-30 WCM Investment Management, LLC 2% 3,388,634 $523,416,548
2025-06-30 Massachusetts Financial Services Co. 2% 3,286,245 $507,601,297
2025-06-30 Sands Capital Management, LLC 2% 2,588,723 $399,860,373

Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Atlassian.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS